Kristen Rinaldi, PA
Physician Assistant · Hartford, CTNPI 1558543546
Payments from drug & device makers
Across 295 payments — averaging $22.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$849
- Sumitomo Pharma America, Inc.$756
- Astellas Pharma US Inc$620
- Pfizer$408
- Bayer$381
- Tolmar, Inc.$323
- plus $3K from 36 others
What the payments were for
- Travel & lodging$330%
- Food & beverage$5,98589%
- Education$70210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 32 | $849 |
| Sumitomo Pharma America, Inc. | 33 | $756 |
| Astellas Pharma US Inc | 16 | $620 |
| Pfizer | 17 | $408 |
| Bayer | 17 | $381 |
| Tolmar, Inc. | 13 | $323 |
| Merck | 14 | $304 |
| Endo Pharmaceuticals Inc. | 18 | $282 |
| AbbVie | 14 | $266 |
| Progenics Pharmaceuticals, Inc. | 11 | $248 |
| Antares Pharma, Inc. | 9 | $213 |
| Urovant Sciences Inc | 11 | $187 |
| Urogen Pharma, Inc. | 5 | $168 |
| Coloplast | 10 | $164 |
| Axonics, Inc. | 3 | $156 |
| Tolmar Pharmaceuticals, Inc. | 7 | $136 |
| Acerus Pharmaceuticals Corporation | 12 | $129 |
| Ferring Pharmaceuticals Inc. | 7 | $123 |
| C. R. Bard, Inc. & Subsidiaries | 5 | $118 |
| Endo USA, Inc. | 4 | $98 |
| Myriad Genetic Laboratories, Inc. | 6 | $83 |
| Vertex | 4 | $81 |
| Boston Scientific | 2 | $70 |
| Immunitybio, Inc. | 2 | $51 |
| Atricure, Inc. | 1 | $51 |
| Accord Healthcare, Inc. | 2 | $45 |
| Dentsply IH Inc. | 3 | $44 |
| Teleflex LLC | 2 | $40 |
| Janssen Scientific Affairs, LLC | 1 | $37 |
| ABC Home Medical Supply, Inc. | 2 | $37 |
| BD | 1 | $37 |
| Hollister Incorporated | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| Photocure Inc | 1 | $21 |
| Halozyme Inc | 1 | $20 |
| Calyxo, Inc. | 1 | $20 |
| Amgen | 1 | $19 |
| Rochester Medical Corporation | 1 | $19 |
| Sanofi | 1 | $19 |
| Myovant Sciences Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Olympus America Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics$123
How this compares
$6,719 in reported general payments places this provider in the 95th percentile of 1,795 physician assistant providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 120 | $134,927 |
| MyrbetriqMirabegron | 31 | $28,028 |
| XyostedTestosterone Enanthate | 19 | $16,591 |
| Tamsulosin Hcl | 233 | $3,490 |
| Methenamine Hippurate | 41 | $2,648 |
| Testosterone | 19 | $2,342 |
| Testosterone Cypionate | 41 | $2,129 |
| Potassium Citrate ErPotassium Citrate | 21 | $2,031 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 71 | $1,416 |
| Cefpodoxime Proxetil | 12 | $947 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 58 | $640 |
| CefuroximeCefuroxime Axetil | 33 | $489 |
| Oxybutynin Chloride ErOxybutynin Chloride | 28 | $476 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 17 | $471 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 62 | $402 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $756 | $134,927120 claims |
| Astellas Pharma US IncMyrbetriq | $620 | $28,02831 claims |
| Antares Pharma, Inc.Xyosted | $213 | $16,59119 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,795 physician assistant providers in Connecticut.
Other physician assistant in Hartford
- Renee ThompsonHartford$14K
- Daniela PrattHartford$10K
- Nicole GrilliHartford$9K
- Jenna LangelloWaterbury$345K
- Gary SpinnerBridgeport$123K
- Jordan MarcouTrumbull$44K
- Mary ElliottGuilford$43K
- Christopher ThompsonGroton$42K
- Michael LalondeNew Haven$35K
- Kristine LaneMiddletown$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.